Home / Artifacts / Dementia with Lewy Bodies vs Parkinson's Disease Compar

📖

Dementia with Lewy Bodies vs Parkinson's Disease Comparison

active

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-dementia-lewy-bodies-parki

Related Entities

diseases-dementia-lewy-bodies-parkinsons

Metadata

slug	diseases-dementia-lewy-bodies-parkinsons
kg_node_id	None
entity_type	disease

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

Outgoing

161

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (246)

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%

related🧫Experiment: Multi-Ethnic PD GWAS60%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%

related🧫Validation: Membrane-Nucleation in iPSC Neurons60%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%

mentions🧪Smartphone-Detected Motor Variability Correction60%

mentions🧪Competitive APOE4 Domain Stabilization Peptides60%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%

related🧫Prodromal Parkinson's Disease Biomarker Development — E60%

related🧫CRISPR Gene Correction Approaches for CBS/PSP60%

related🧫MLCS Quantification in Parkinson's Disease60%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%

mentions🧫Dexamethasone treatment study in α-synuclein mice60%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%

related🧫AAV-LRRK2 IND-Enabling Study Design60%

related🧫Alpha-Synuclein Seed Amplification Assay Validation60%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%

related🧫Antiviral Therapy Trial for Parkinson's Disease60%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%

related🧫Parkinson's Disease Subtype Classification — Precision 60%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%

related🧫Combination Therapy Sequencing in Parkinson's Disease60%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%

mentions🧫TLR expression analysis in Parkinson's disease patients60%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%

related🧫Ferroptosis Validation in Parkinson's Disease60%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice60%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation60%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%

mentions🧫iPSC-derived astrocyte-neuron co-culture mitochondrial trans60%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides60%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade60%

related🧫Macroautophagy Dysfunction in PD - Experiment Design60%

mentions🧫TLR expression in α-synuclein overexpressing mice60%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%

related🧫Cytochrome Therapeutics60%

mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim55%

mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i55%

mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#55%

mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson55%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise55%

mentions🧫Macroautophagy Dysfunction in PD - Experiment Design55%

mentions🧫Ferroptosis Validation in Parkinson's Disease55%

mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease55%

mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D55%

mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa55%

mentions🧫Combination Therapy Sequencing in Parkinson's Disease55%

mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD55%

mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD55%

mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P55%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 55%

mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 55%

mentions🧫MLCS Quantification in Parkinson's Disease55%

mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 55%

mentions🧫Prodromal Parkinson's Disease Biomarker Development — E55%

mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper55%

mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&55%

mentions🧫Antiviral Therapy Trial for Parkinson's Disease55%

mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas55%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP55%

mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'55%

mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD55%

mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag55%

mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea55%

mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design55%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio55%

mentions🧫Parkinson's Disease Subtype Classification — Precision 55%

mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin55%

mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&55%

mentions🧫Cytochrome Therapeutics55%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise55%

mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr55%

mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&55%

mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me55%

mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki55%

mentions🧫Experiment: Multi-Ethnic PD GWAS55%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise55%

mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation55%

mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown55%

mentions🧫Validation: Membrane-Nucleation in iPSC Neurons55%

mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 55%

mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#55%

mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson55%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne55%

mentions🧫AAV-LRRK2 IND-Enabling Study Design55%

mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation55%

mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#55%

mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin55%

mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di55%

mentions🧫Alpha-Synuclein Seed Amplification Assay Validation55%

mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De55%

mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise55%

mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back55%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera55%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD55%

related🧫Ferroptosis Validation in Parkinson's Disease54%

related🧪Smartphone-Detected Motor Variability Correction54%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%

related🧫Combination Therapy Sequencing in Parkinson's Disease54%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%

related🧫Dexamethasone treatment study in α-synuclein mice54%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%

related🧫Cytochrome Therapeutics54%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%

related🧫Experiment: Multi-Ethnic PD GWAS54%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%

related🧫Validation: Membrane-Nucleation in iPSC Neurons54%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%

related🧪Competitive APOE4 Domain Stabilization Peptides54%

related🧫MLCS Quantification in Parkinson's Disease54%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides54%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%

related🧫Macroautophagy Dysfunction in PD - Experiment Design54%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer54%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%

related🧫Antiviral Therapy Trial for Parkinson's Disease54%

related🧫Alpha-Synuclein Seed Amplification Assay Validation54%

related🧫Parkinson's Disease Subtype Classification — Precision 54%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%

related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation54%

related🧫CRISPR Gene Correction Approaches for CBS/PSP54%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%

related🧪Enteric Nervous System Prion-Like Propagation Blockade54%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%

related🧫iPSC-derived astrocyte-neuron co-culture mitochondrial trans54%

related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice54%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%

related🧫TLR expression in α-synuclein overexpressing mice54%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%

related🧫AAV-LRRK2 IND-Enabling Study Design54%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%

related🧫Prodromal Parkinson's Disease Biomarker Development — E54%

related🧫TLR expression analysis in Parkinson's disease patients54%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%

related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

related🔬What are the mechanisms underlying mechanistic role of apoe 50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

mentions🧪APOE Isoform Conversion Therapy50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬How does metabolic reprogramming (glucose metabolism shifts,50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

related🔬What are the most promising therapeutic strategies for targe50%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬What are the mechanisms underlying digital biomarkers and ai50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%

related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%

💬 Discussion

Loading comments...